Neuronetics (STIM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Neuronetics (STIM) is Neutral.

The composite score behind that read is -0.15, weighing +0.00 of bullish evidence against -0.44 bearish.

Neuronetics last closed at $2.13, -0.47% on the session.

Against the IVW growth benchmark the position is -1.27% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for STIM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Neuronetics in the 7th percentile on return on equity, where 100 is best.

Neuronetics is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $163.06M.

StockMap tracks Neuronetics as the 97th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Neuronetics ranks 110th of 140 in the group, against a group median of -0.03.